Factors Impacting Early Mortality in Tuberculosis/HIV Patients: Differences between Subjects Naïve to and Previously Started on HAART

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Schmaltz, Carolina Arana Stanis ^a   Santoro Lopes, Guilherme ^b   Lourenço, Maria Cristina ^a   Morgado, Mariza Gonçalves ^a   de Velasque, Luciane Souza ^a,c   Rolla, Valéria Cavalcanti ^a  

^a Funda??o Oswaldo Cruz   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MILIARY TUBERCULOSIS; MORTALITY; PROSPECTIVE STUDY; RISK FACTOR; TUBERCULOSIS;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84866710514     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045704     Document Type: Article

References (28)

1. WHO (2006) The Global Plan to Stop TB, 2006-2015. Geneva: WHO Stop TB Partnership.
2. Glaziou P, Floyd K, Korenromp EL, Sismanidis C, Bierrenbach AL, et al. (2011) Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality. Bull World Health Organ 89: 573-582.
3. Elliott AM, Halwiindi B, Hayes RJ, Luo N, Mwinga AG, et al. (1995) The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia. Trans R Soc Trop Med Hyg 89: 78-82.
4. Nunn P, Brindle R, Carpenter L, Odhiambo J, Wasunna K, et al. (1992) Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality. Am Rev Respir Dis 146: 849-854.
5. Zachariah R, Fitzgerald M, Massaquoi M, Acabu A, Chilomo D, et al. (2007) Does antiretroviral treatment reduce case fatality among HIV-positive patients with tuberculosis in Malawi? Int J Tuberc Lung Dis 11: 848-853.
6. Worodria W, Massinga-Loembe M, Mazakpwe D, Luzinda K, Menten J, et al. (2011) Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy. J Acquir Immune Defic Syndr 58: 32-37.
7. Ackah AN, Coulibaly D, Digbeu H, Diallo K, Vetter KM, et al. (1995) Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote d'Ivoire. Lancet 345: 607-610.
8. Ansari NA, Kombe AH, Kenyon TA, Hone NM, Tappero JW, et al. (2002) Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998. Int J Tuberc Lung Dis 6: 55-63.
9. Chaisson RE, Schecter GF, Theuer CP, Rutherford GW, Echenberg DF, et al. (1987) Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am Rev Respir Dis 136: 570-574.
10. Greenberg AE, Lucas S, Tossou O, Coulibaly IM, Coulibaly D, et al. (1995) Autopsy-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan, Cote d'Ivoire. Aids 9: 1251-1254.
11. Gutierrez EB, Zanetta DM, Saldiva PH, Capelozzi VL, (2002) Autopsy-proven determinants of death in HIV-infected patients treated for pulmonary tuberculosis in Sao Paulo, Brazil. Pathol Res Pract 198: 339-346.
12. Taarnhoj GA, Engsig FN, Ravn P, Johansen IS, Larsen CS, et al. (2011) Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007. BMC Pulm Med 11: 26.
13. Schmaltz CA, Sant'Anna FM, Neves SC, Velasque Lde S, Lourenco MC, et al. (2009) Influence of HIV infection on mortality in a cohort of patients treated for tuberculosis in the context of wide access to HAART, in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 52: 623-628.
14. Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, et al. (2011) Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med 365: 1471-1481.
15. Velasco M, Castilla V, Sanz J, Gaspar G, Condes E, et al. (2009) Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis. J Acquir Immune Defic Syndr 50: 148-152.
16. Lawn SD, Myer L, Edwards D, Bekker LG, Wood R, (2009) Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. Aids 23: 1717-1725.
17. Moore D, Liechty C, Ekwaru P, Were W, Mwima G, et al. (2007) Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. Aids 21: 713-719.
18. Akksilp S, Karnkawinpong O, Wattanaamornkiat W, Viriyakitja D, Monkongdee P, et al. (2007) Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand. Emerg Infect Dis 13: 1001-1007.
19. Franke MF, Robins JM, Mugabo J, Kaigamba F, Cain LE, et al. (2011) Effectiveness of early antiretroviral therapy initiation to improve survival among HIV-infected adults with tuberculosis: a retrospective cohort study. PLoS Med 8: e1001029.
20. Sanguanwongse N, Cain KP, Suriya P, Nateniyom S, Yamada N, et al. (2008) Antiretroviral therapy for HIV-infected tuberculosis patients saves lives but needs to be used more frequently in Thailand. J Acquir Immune Defic Syndr 48: 181-189.
21. Tabarsi P, Saber-Tehrani AS, Baghaei P, Padyab M, Mansouri D, et al. (2009) Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIV. J Int AIDS Soc 12: 14.
22. Varma JK, Nateniyom S, Akksilp S, Mankatittham W, Sirinak C, et al. (2009) HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study. BMC Infect Dis 9: 42.
23. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, et al. (2011) Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med 365: 1492-1501.
24. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S, (2006) Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr 43: 42-46.
25. Vijay S, Kumar P, Chauhan LS, Rao SV, Vaidyanathan P, (2011) Treatment outcome and mortality at one and half year follow-up of HIV infected TB patients under TB control programme in a district of South India. PLoS One 6: e21008.
26. Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, et al. (2011) Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med 365: 1482-1491.
27. Gadkowski LB, Hamilton CD, Allen M, Fortenberry ER, Luffman J, et al. (2009) HIV-specific health care utilization and mortality among tuberculosis/HIV coinfected persons. AIDS Patient Care STDS 23: 845-851.
28. Lawn SD, Wood R, (2011) Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis. J Infect Dis 204Suppl 4: S1159-1167.